Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Virology. 2007 Nov 26;372(1):107. doi: 10.1016/j.virol.2007.10.016

Figure 5. Effect of REP 9 on retroviral LCMV pseudotypes.

Figure 5

(A) Addition of drug at or post infection: VeroE6 cells were treated with 2 μM REP 9 during infection (0 h) and 3 or 6 hours post infection (+ 3 h, +6 h) with replication-deficient pseudotypes of LCMV (MOI = 1). Infection was assessed after 48 hours as in Fig. 4 (mean ± SD; n = 3). (B) Effect of the pre-treatment of cells with REP 9 on pseudotype infection: Cells were pre-treated with 2 μM REP 9 for 6, 2, and 1 hour, washed extensively and then infected with replication-deficient pseudotypes of LCMV (MOI = 1). Infection was assessed after 48 hours as in (A).